Treatment.com AI to Present at the 2024 Cantech Letter Conference in Toronto, ON
2024年10月1日 - 4:00PM
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939)
(“Treatment”), a healthcare tech company focused on transforming
patient care with AI-driven Clinical insights, is pleased to
announce its participation at the upcoming Cantech Letter
Investment Conference on Wednesday, October 9, 2024 in Toronto
Ontario. Dr. Essam Hamza, CEO of Treatment.com AI , will be
attending the conference, delivering an investor presentation and
participating in scheduled 1-on-1 meetings with investors at the
conference.
2024 Cantech Letter Conference
Date: Wednesday, October 9, 2024 Time: 11:00 AM Eastern Time in
Track 1 Location: Arcadian Loft, 8th floor, 401 Bay Street,
Toronto, ON Contact: tara@cantechletter.com to register
More info: https://www.cantechletter.com/conference/
Dr. Essam Hamza, CEO of Treatment.com AI,
commented, "We are looking forward to presenting at Cantech, a
great conference providing a timely opportunity to talk to
investors, analysts and the investment community. The healthcare
system is at the precipice of substantial modernization and we
believe that our proprietary platform can help with reducing its
inefficiencies, reducing administration headaches, and ultimately
improving patient access and care."
Dr. Essam Hamza will also be conducting
in-person 1x1 meetings at the conference venue on Wednesday,
October 9, 2024. To schedule 1-on-1 investor meetings with
Treatment and attend the 2024 Cantech Letter Conference, please
contact Tara Whittet at tara@cantechletter.com. 1x1 meetings
will be conducted in person at the conference venue: Arcadian Loft,
Toronto.
About Cantech Letter Conference
The Cantech Letter Conference, recognized as
Canada's foremost technology investment event, provides up and
coming technology companies with the unique opportunity to showcase
their innovations and growth strategies, and participate in
individual 1-on-1 meetings with potential investors and capital
markets professionals. The conference serves as a hub for
networking, knowledge exchange, and investment opportunities, while
also featuring panel discussions with industry experts to offer
insights into current trends, challenges, and opportunities within
the technology sector.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and
best clinical practices to positively improve the healthcare sector
and impact current inefficiencies and challenges. With the input of
hundreds of healthcare professionals globally, Treatment has built
a comprehensive, personalized healthcare AI engine, the Global
Library of Medicine (GLM). With more than ~10,000 expert medical
reviews, the GLM delivers tested clinical information and support
to all healthcare professionals, as well as providing recommended
tests (physical and lab), x-rays, and billing codes. The GLM helps
healthcare professionals (doctor, nurse or pharmacist) reduce their
administrative burden; create more time for needed face to face
patient appointments and enables greater consistency in quality of
patient support. Treatment’s GLM platform, through supporting
healthcare professionals, allows for the inclusion of
disenfranchised communities. To learn more about Treatment’s
products and services: www.treatment.com or email:
info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
ehamza@treatment.com
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888)
788-8955
Cautionary Statements
This news release contains forward-looking
statements that are based on Treatment.com AI’s expectations,
estimates and projections regarding its business and the economic
environment in which it operates. Although Treatment.com believes
the expectations expressed in such forward-looking statements are
based on reasonable assumptions, such statements are not guarantees
of future performance and involve risks and uncertainties that are
difficult to control or predict. Therefore, actual outcomes and
results may differ materially from those expressed in these
forward-looking statements, and readers should not place undue
reliance on such statements. These forward-looking statements speak
only as of the date on which they are made, and Treatment.com
undertakes no obligation to update them publicly to reflect new
information or the occurrence of future events or circumstances
unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility
for the adequacy or accuracy of this release.